620 algorithm-development-"Multiple"-"Prof" "UNIS" Fellowship positions in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- ;
- University of Nottingham
- University of Birmingham
- University of Oxford
- Nature Careers
- University of London
- Queen's University Belfast
- UNIVERSITY OF MELBOURNE
- UNIVERSITY OF SOUTHAMPTON
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- UNIVERSITY OF SURREY
- KINGS COLLEGE LONDON
- University of Cambridge
- University of Leeds
- Imperial College London
- King's College London
- Queen's University Belfast;
- University of Glasgow
- The University of Southampton
- CRANFIELD UNIVERSITY
- Cardiff University
- QUEENS UNIVERSITY BELFAST
- University of Bristol
- University of Sheffield
- University of Surrey
- City University London
- UCL;
- University of Manchester
- Aston University
- Sheffield Hallam University
- University of Surrey;
- ; Technical University of Denmark
- ; University of Glasgow
- Brunel University
- Cranfield University
- Nottingham Trent University
- Plymouth University
- The University of Edinburgh;
- University of Exeter;
- University of Hull
- University of Leeds;
- University of Leicester
- University of Liverpool
- University of Newcastle
- University of the West of England
- ; University of Aberdeen
- ; University of Exeter
- ; University of Oxford
- ; University of Warwick
- AALTO UNIVERSITY
- Anglia Ruskin University;
- Birmingham City University
- DURHAM UNIVERSITY
- Durham University
- Glasgow Caledonian University;
- Glasgow School of Art;
- Lancaster University
- Lancaster University;
- London School of Hygiene & Tropical Medicine;
- Loughborough University
- Manchester Metropolitan University
- Nuffield College
- Robert Gordon University;
- Technical University of Denmark
- UNIVERSITY OF GREENWICH
- University College London
- University of Aberdeen;
- University of Bradford;
- University of Brighton
- University of Cambridge;
- University of Exeter
- University of Greenwich
- University of Nottingham;
- University of Oxford;
- University of Plymouth;
- University of Southampton;
- University of Stirling
- University of Sussex
- University of Warwick;
- 69 more »
- « less
-
Field
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving
-
, the role-holder will be part of the Centre’s central ECR cohort, with support from a cohort director / Centre deputy director and access to a Centre-wide ECR development programme—for example, co-writing
-
, the role-holder will be part of the Centre’s central ECR cohort, with support from a cohort director / Centre deputy director and access to a Centre-wide ECR development programme—for example, co-writing
-
these interactions we are working to develop better diagnostic tests and future vaccines and novel therapeutics. Staphylococcus aureus is a major opportunistic pathogen and the leading bacterial cause of death in most
-
co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and
-
Development Lead. You will be responsible for contributions to a major new programme of research investigating ethical questions and public views concerning research using post-mortem brains. The project
-
theoretical knowledge and practical experience of quantitative research approaches and methods to lead on the development and implementation of research projects. As part of this role, you will also support
-
science and artificial intelligence concepts and tools to solve complex problems. Candidates will also be developing machine learning techniques and applying them at scale to specific projects with regular
-
applications for an Early-Career Clinical Research Fellow in Patient Safety. This is an integrated clinical academic (ICA) career development role. The post holder is expected to become a next-generation leader
-
molecular and structural mechanisms is essential for therapeutic development. Using E3 activity-based chemical probes, we have substantially expanded the known landscape of E3 ligase subtypes—effectively